In daily pediatric practice, shared decision-making is already happening, often more than is acknowledged,” a pediatrician ...

California Gov. Gavin Newsom announced his office was filing a civil rights complaint with HHS accusing CMS Administrator Mehmet Oz of discrimination.

European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...

The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.

To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...

First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous funding environment ...

The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...

Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...

As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.

Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work ...

The lawsuit’s outcome could have major implications for millions of Americans, especially after Congress voted in 2025 to slash state Medicaid funding, a major source of care for people with ...